版本:
中国

BRIEF-Regen Biopharma sees positive results on medicinal chemistry optimization

May 16 Regen Biopharma Inc:

* Regen Biopharma sees additional positive results on its medicinal chemistry optimization for modulating NR2f6 checkpoint for treating cancer and autoimmune diseases Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐